Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis

Abstract Background Symmetric dimethylarginine (SDMA) is a methylated arginine derived from intranuclear methylation of l‐arginine by protein‐arginine methyltransferase and released into circulation after proteolysis. It is primarily eliminated by renal excretion, and its concentration is highly cor...

Full description

Bibliographic Details
Main Authors: André Nanny Vieira Le Sueur, Silvano Salgueiro Geraldes, Alessandra Melchert, Regina Kiomi Takahira, Michael Coyne, Rachel Murphy, Donald Szlosek, Priscylla Tatiana Chalfun Guimarães‐Okamoto
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.15612
id doaj-41b3c62de62044a297cb6844ac34e355
record_format Article
spelling doaj-41b3c62de62044a297cb6844ac34e3552020-11-25T01:58:53ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762019-11-013362635264310.1111/jvim.15612Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysisAndré Nanny Vieira Le Sueur0Silvano Salgueiro Geraldes1Alessandra Melchert2Regina Kiomi Takahira3Michael Coyne4Rachel Murphy5Donald Szlosek6Priscylla Tatiana Chalfun Guimarães‐Okamoto7Department of Veterinary Clinics, School of Veterinary Medicine and Animal Science São Paulo State University—UNESP São Paulo BrazilDepartment of Veterinary Clinics, School of Veterinary Medicine and Animal Science São Paulo State University—UNESP São Paulo BrazilDepartment of Veterinary Clinics, School of Veterinary Medicine and Animal Science São Paulo State University—UNESP São Paulo BrazilDepartment of Veterinary Clinics, School of Veterinary Medicine and Animal Science São Paulo State University—UNESP São Paulo BrazilIDEXX Laboratories Inc Westbrook MaineIDEXX Laboratories Inc Westbrook MaineIDEXX Laboratories Inc Westbrook MaineDepartment of Veterinary Clinics, School of Veterinary Medicine and Animal Science São Paulo State University—UNESP São Paulo BrazilAbstract Background Symmetric dimethylarginine (SDMA) is a methylated arginine derived from intranuclear methylation of l‐arginine by protein‐arginine methyltransferase and released into circulation after proteolysis. It is primarily eliminated by renal excretion, and its concentration is highly correlated with glomerular filtration rate (GFR) in animals and humans and is an earlier indicator of kidney dysfunction than serum creatinine concentration (sCr). Objectives To evaluate and quantify the effects of IV fluid therapy (IF) or intermittent hemodialysis (IH) on renal function in a randomized group of dogs previously diagnosed with International Renal Interest Society (IRIS) stage 4 chronic kidney disease (CKD). Animals Twenty‐four client‐owned dogs with naturally occurring CKD. Methods Serum from 14 dogs treated by IH and 10 dogs treated with IF was submitted for measurement of sCr and SDMA. Dogs in each treatment group received up to 5 treatment sessions, administered 48 hours apart. Results Significant differences (P ≤ .05) were seen between treatment groups, but dogs from the IH group were the most affected based on SDMA (P < .001), sCr (P < .001), and blood urea (P < .001) concentrations. Furthermore, for each 10% increase in urea reduction ratio, there was a 6.2 μg/dL decrease in SDMA (P = .002). Conclusions and Clinical Importance Although SDMA is dialyzable biomarker and despite its removal by IH, SDMA correlates better with renal function than does sCr in dogs with CKD undergoing IF and IH.https://doi.org/10.1111/jvim.15612caninedialysisglomerular filtration rateSDMA renal biomarker
collection DOAJ
language English
format Article
sources DOAJ
author André Nanny Vieira Le Sueur
Silvano Salgueiro Geraldes
Alessandra Melchert
Regina Kiomi Takahira
Michael Coyne
Rachel Murphy
Donald Szlosek
Priscylla Tatiana Chalfun Guimarães‐Okamoto
spellingShingle André Nanny Vieira Le Sueur
Silvano Salgueiro Geraldes
Alessandra Melchert
Regina Kiomi Takahira
Michael Coyne
Rachel Murphy
Donald Szlosek
Priscylla Tatiana Chalfun Guimarães‐Okamoto
Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis
Journal of Veterinary Internal Medicine
canine
dialysis
glomerular filtration rate
SDMA renal biomarker
author_facet André Nanny Vieira Le Sueur
Silvano Salgueiro Geraldes
Alessandra Melchert
Regina Kiomi Takahira
Michael Coyne
Rachel Murphy
Donald Szlosek
Priscylla Tatiana Chalfun Guimarães‐Okamoto
author_sort André Nanny Vieira Le Sueur
title Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis
title_short Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis
title_full Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis
title_fullStr Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis
title_full_unstemmed Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis
title_sort symmetric dimethylarginine concentrations in dogs with international renal interest society stage 4 chronic kidney disease undergoing intermittent hemodialysis
publisher Wiley
series Journal of Veterinary Internal Medicine
issn 0891-6640
1939-1676
publishDate 2019-11-01
description Abstract Background Symmetric dimethylarginine (SDMA) is a methylated arginine derived from intranuclear methylation of l‐arginine by protein‐arginine methyltransferase and released into circulation after proteolysis. It is primarily eliminated by renal excretion, and its concentration is highly correlated with glomerular filtration rate (GFR) in animals and humans and is an earlier indicator of kidney dysfunction than serum creatinine concentration (sCr). Objectives To evaluate and quantify the effects of IV fluid therapy (IF) or intermittent hemodialysis (IH) on renal function in a randomized group of dogs previously diagnosed with International Renal Interest Society (IRIS) stage 4 chronic kidney disease (CKD). Animals Twenty‐four client‐owned dogs with naturally occurring CKD. Methods Serum from 14 dogs treated by IH and 10 dogs treated with IF was submitted for measurement of sCr and SDMA. Dogs in each treatment group received up to 5 treatment sessions, administered 48 hours apart. Results Significant differences (P ≤ .05) were seen between treatment groups, but dogs from the IH group were the most affected based on SDMA (P < .001), sCr (P < .001), and blood urea (P < .001) concentrations. Furthermore, for each 10% increase in urea reduction ratio, there was a 6.2 μg/dL decrease in SDMA (P = .002). Conclusions and Clinical Importance Although SDMA is dialyzable biomarker and despite its removal by IH, SDMA correlates better with renal function than does sCr in dogs with CKD undergoing IF and IH.
topic canine
dialysis
glomerular filtration rate
SDMA renal biomarker
url https://doi.org/10.1111/jvim.15612
work_keys_str_mv AT andrenannyvieiralesueur symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis
AT silvanosalgueirogeraldes symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis
AT alessandramelchert symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis
AT reginakiomitakahira symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis
AT michaelcoyne symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis
AT rachelmurphy symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis
AT donaldszlosek symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis
AT priscyllatatianachalfunguimaraesokamoto symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis
_version_ 1724967447083089920